Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of GLP-1 or analogs in treatment of myocardial infarction

Use of GLP-1 or analogs in treatment of myocardial infarction

US Patent 6277819 · Granted Aug 21, 2001

Estimated economic value: $805,041,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Somatostatin receptor antagonists and glucose control or hypoglycemia2012
Method of controlling tight blood glucose by somatostatin receptor antagonists2011
Methods for identifying compounds for treating diabetes mellitus2008
Use of GLP-1 analogs and derivatives administered peripherally in regulation of 2007
Use of GLP-1 or analogs in treatment of myocardial infarction2004
Use of GLP-1 analogs and derivative adminstered peripherally in regulation of ob2003
Pharmaceutical composition for the treatment of functional dyspepsia and/or irri2002
Peptide2001
Use of GLP-1 analogs and derivatives administered peripherally in regulation of 2001
Use of GLP-1 or analogs to abolish catabolic changes after surgery1999
Use of a peptide1997